Clindamycin vs Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D

## Clindamycin vs Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D: Overview

This comparison examines the pharmacological differences between **Clindamycin** and **Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D**.

## Mechanism of Action

**Clindamycin**: Binds 50S ribosomal subunit inhibiting protein synthesis.

## Pharmacokinetics

**Half-life**: Clindamycin — 2-3 hours; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A.

## Chemical Properties

**Molecular Formula**: Clindamycin — C18H33ClN2O5S; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A.

**Molecular Weight**: Clindamycin — 424.9830 g/mol; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A.

**Type**: Clindamycin — Small molecule; Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — Vaccine component.